Global Immunosuppressant Drugs Market Size & Outlook
Global immunosuppressant drugs market, 2016-2027 (US$M)
Related Markets
Global immunosuppressant drugs market highlights
- The global immunosuppressant drugs market generated a revenue of USD 95,906.0 million in 2020 and is expected to reach USD 149,677.5 million by 2027.
- The market is expected to grow at a CAGR (2021 - 2027) of 6.6% by 2027.
- In terms of segment, monoclonal antibodies accounted for a revenue of USD 71,353.5 million in 2020.
- Monoclonal Antibodies is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2020.
- Country-wise, Russia is expected to register the highest CAGR from 2021 to 2027.
Global data book summary
| Market revenue in 2020 | USD 95,906.0 million |
| Market revenue in 2027 | USD 149,677.5 million |
| Growth rate | 6.6% (CAGR from 2020 to 2027) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Monoclonal Antibodies |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Calcineurin Inhibitors, MTOR Inhibitors, Antiproliferative Agents, Monoclonal Antibodies |
Other key industry trends
- In terms of revenue, the North America accounted for 44.7% of the global immunosuppressant drugs market in 2020.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2027.
- By country, Russia is the fastest growing regional market and is projected to reach USD 1,049.4 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunosuppressant Drugs Market Scope
Immunosuppressant Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| No records found. | ||||
Global immunosuppressant drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunosuppressant drugs market will help companies and investors design strategic landscapes.
Monoclonal antibodies was the largest segment with a revenue share of 74.4% in 2020. Horizon Databook has segmented the Global immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.
- Global Immunosuppressant Drugs Drug Class Outlook (Revenue, USD Million, 2016-2027)
- Calcineurin Inhibitors
- Antiproliferative Agents
- mTOR Inhibitors
- Monoclonal Antibodies
- Others
- Global Immunosuppressant Drugs Application Outlook (Revenue, USD Million, 2016-2027)
- Autoimmune Diseases
- Systemic Lupus Erythematosus (SLE)
- Psoriasis
- Rheumatoid Arthritis
- Multiple Sclerosis
- Crohn's Disease
- Others
- Organ Transplants
- Lung
- Pancreas
- Kidney
- Liver
- Heart
- Others
- Other Applications
- Autoimmune Diseases
- Global Immunosuppressant Drugs Route of Administration Outlook (Revenue, USD Million, 2016-2027)
- Oral
- Injectables
- Global Immunosuppressant Drugs Distribution Channel Outlook (Revenue, USD Million, 2016-2027)
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
Reasons to subscribe to Global immunosuppressant drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global immunosuppressant drugs market databook
-
Our clientele includes a mix of immunosuppressant drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global immunosuppressant drugs market, including forecasts for subscribers. This global databook contains high-level insights into Global immunosuppressant drugs market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Global immunosuppressant drugs market size, by regions, 2016-2027 (US$M)
Top 10 countries: Immunosuppressant drugs market size, 2020 (US$M)
Global immunosuppressant drugs market share, by application, 2020 & 2027 (%, US$M)
Immunosuppressant drugs market: Opportunity assessment by country
Global immunosuppressant drugs market, by region, 2020 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
